APG Asset Management
SRPT icon

APG Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

APG Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,600
Closed -$1.28M – 941
2021
Q2 		$1.28M Sell
19,600
-161,840
-89% -$12.3M ﹤0.01% 741
2021
Q1 		$11.5M Buy
181,440
+38,618
+27% +$3.56M 0.02% 472
2020
Q4 		$19.9M Sell
142,822
-3,515
-2% -$521K 0.03% 442
2020
Q3 		$17.5M Buy
146,337
+43,907
+43% +$6.67M 0.03% 466
2020
Q2 		$14.6M Sell
102,430
-6,402
-6% -$871K 0.03% 477
2020
Q1 		$10.6M Buy
108,832
+33,281
+44% +$3.8M 0.02% 538
2019
Q4 		$8.69M Buy
75,551
+18,000
+31% +$1.82M 0.01% 600
2019
Q3 		$3.98M Buy
+57,551
New +$6.8M 0.01% 740

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management's SRPT Position: Q3 2021 in Review

APG Asset Management sold out of Sarepta Therapeutics (SRPT) in Q3 2021, closing a stake of 19,600 shares — an estimated $1.28M sold.

APG Asset Management first reported a position in SRPT in Q3 2019 and held it in 8 quarters. The position peaked at $19.9M in Q4 2020. 306 funds tracked by Wall St. Rank hold SRPT as of Q3 2021.

  • APG Asset Management reported no remaining Sarepta Therapeutics position as of Q3 2021 after selling out during the quarter.
  • APG Asset Management sold 19,600 Sarepta Therapeutics shares in Q3 2021, an estimated $1.28M.
  • APG Asset Management first reported a position in Sarepta Therapeutics in Q3 2019 and held it in 8 quarters.
  • APG Asset Management's Sarepta Therapeutics position peaked at $19.9M in Q4 2020.
  • 306 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2021.

Based on APG Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.